Mycophenolic acid (MPA) AUC(0-12h) in stable liver transplant patients treated with a monotherapy of mycophenolate mofetil (MMF) for calcineurin inhibitors (CNI) induced nephrotoxicity

被引：0
|
作者：
Dharancy, S.
Hulin, A.
Declerck, N.
Blanchet, B.
Boleslawski, E.
Canva, V.
Mathurin, P.
Pruvot, F. R.
机构：
[1] Ctr Hosp Reg & Univ Lille, Hop Huriez, Hepatol & Transplant Unit, F-59037 Lille, France
[2] Hop Henri Mondor, Dept Pharmacol, AP HP, F-94010 Creteil, France
来源：
JOURNAL OF HEPATOLOGY | 2007年 / 46卷
关键词：
D O I：
10.1016/S0168-8278(07)61751-6
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
153
引用
收藏
页码：S68 / S68
页数：1
相关论文
共 24 条
  • [1] Mycophenolic acid (MPA) AUC(0-12H) in stable liver transplant patients treated with a monotherapy of mycophenolate mofetil (MMF) for calcineurin inhibitors (CNI) induced nephrotoxicity
    Dharancy, Sebastien
    Hulin, Anne
    Declerck, Nicole
    Blanchet, Benoiet
    Boleslawski, Emmanuel
    Canva, Valerie
    Mathurin, Philippe
    Pruvot, Francois-Rene
    [J]. HEPATOLOGY, 2006, 44 (04) : 406A - 407A
  • [2] Measurement of circulatory unhydrolysed mycophenolate mofetil (MMF) to mycophenolic acid (MPA) with intravenous MMF in post liver transplant patients.
    Jain, Ashok
    Mohanka, Ravi
    Tai, Kwong
    Orloff, Mark
    Abt, Peter
    Bozorgzadeh, Adel
    [J]. LIVER TRANSPLANTATION, 2006, 12 (05) : C125 - C125
  • [3] Monitoring mycophenolic acid (MPA) plasma levels may benefit the management of liver transplant recipients treated with mycophenolate mofetil (MMF).
    Brown, NW
    Gonde, C
    Adams, J
    Tredger, JM
    [J]. THERAPEUTIC DRUG MONITORING, 2003, 25 (04) : 513 - 513
  • [4] Pharmacokinetics (PK) and pharmacodynamics (PD) of mycophenolic acid (MPA) in stable renal transplant recipients treated with suboptimal doses of mycophenolate mofetil (MMF)
    Brunet, M
    Martorell, J
    Oppenheimer, F
    Vilardell, J
    Millán, O
    Carrillo, M
    Corbella, J
    [J]. TRANSPLANTATION, 1999, 67 (07) : S205 - S205
  • [5] Mycophenolate mofetyl (MMF) monotherapy is an attractive strategy in liver transplant recipients with severe side effects of calcineurin inhibitors (CNI)
    Dharancy, Sebastien
    Sammartino, Cinzia
    Hulin, Anne
    Declerck, Nicole
    Iannelli, Antonio
    Mathurin, Philippe
    Boleslawski, Emmanuel
    Gugenheim, Jean
    Pruvot, Francois Rene
    [J]. HEPATOLOGY, 2006, 44 (04) : 405A - 406A
  • [6] Mycophenolate mofetyl (MMF) monotherapy is an attractive strategy in liver transplant recipients with severe side effects of calcineurin inhibitors (CNI).
    Dharancy, S
    Sammartrino, C
    Declerck, N
    Iannelli, A
    Mathurn, P
    Gugenheim, J
    Pruvot, FR
    [J]. LIVER TRANSPLANTATION, 2006, 12 (05) : C44 - C44
  • [7] Efficacy and Safety of Mycophenolate Mofetil Monotherapy in Liver Transplant Patients With Renal Failure Induced by Calcineurin Inhibitors
    Barrera Pulido, L.
    Alamo Martinez, J. M.
    Pareja Ciuro, F.
    Gomez Bravo, M. A.
    Serrano Diez-Canedo, J.
    Bernal Bellido, C.
    Suarez Artacho, G.
    Garcia Gonzalez, I.
    Pascasio Acevedo, J. M.
    Bernardos Rodriguez, A.
    [J]. TRANSPLANTATION PROCEEDINGS, 2008, 40 (09) : 2985 - 2987
  • [8] Evolution of chronic renal dysfunction after conversion from calcineurin inhibitors (CNI) to mycophenolate mofetil monotherapy in liver transplant recipients
    Manrique, Alejandro
    Jimenez, Carlos
    Ortega, Patricia
    Abradelo, Manuel
    Meneu, Juan C.
    Gimeno, Alberto
    Perez, Baltasar
    Calvo, Jorge
    Donat, Maria
    Cambra, Felix
    Lopez, Rose M.
    Morales, Jose M.
    Moreno, Enrique
    [J]. TRANSPLANT INTERNATIONAL, 2007, 20 : 32 - 32
  • [9] Mycophenolate mofetil (MMF) in patients who cannot receive calcineurin inhibitors (CNI) during the early postoperative period of liver transplantation (LT)
    Mendoza, Miguel-Angel
    Londono, Maria-Carlota
    Rimola, Antoni
    [J]. HEPATOLOGY, 2006, 44 (04) : 416A - 417A
  • [10] Sequential determination of pharmacokinetics and pharmacodynamics of mycophenolic acid in liver transplant patients treated with mycophenolate mofetil
    Brunet, M
    Cirera, I
    Martorell, J
    Vidal, E
    Millán, O
    Jiménez, O
    Rojo, I
    Londoño, MC
    Rimola, A
    [J]. TRANSPLANTATION, 2006, 81 (04) : 541 - 546
123